..., which represents less than 1% of the circulating total amount (0.2–0.6 ng/ml), but is 20-fold higher in the interstitial fluid (3.6–10 ng/ml) in close proximity to target tissues. atherothrombosis chronic renal failure diabetes endothelium insulin-like growth factor-1 (IGF-1) myocardial...

... 9 2009 21 9 2009 cancer inflammation insulin insulin-like growth factor-1 (IGF-1) mitogen-activated protein kinase (MAPK) obesity p21Ras Insulin resistance is a state of reduced sensitivity of insulin-responsive tissues to insulin and its key consequences include...

... compilation © 2008 Biochemical Society 2008 diabetes glucagon insulin-like growth factor-1 (IGF-1) insulin-like growth factor-binding protein (IFGBP) obesity IGFs (insulin-like growth factors) induce both glucose and amino acid uptake [ 1 – 4 ]. The amount of circulating IGFs are abundant...

... ]. Thus the aim of the present study was to examine the effects of GH treatment primarily on the incidence of VTs and, secondarily, on infarct size. action potential cardioprotection growth hormone (GH) insulin-like growth factor-1 (IGF-1) myocardial infarction ventricular arrhythmia...